The main objective of infant follow-on formulas, consumed from the age of 6 to 12 months, is to mimic the composition of breast milk in order to meet the nutritional needs of infant. In this context, their composition is governed in Europe by a strict regulation that has evolved in 2020 to force manufacturers to improve the nutritional profile of the formulas. The objective of this dataset was to collect the ingredient lists and nutritional values of infant follow-on formulas present on the world market with a focus on the lipid fraction. The data collection was carried out from December 2020 to April 2021 directly on the product packaging or on the websites of the different brands. Only "classic" infant follow-on formulas that are widely consumed were listed. Thus, the ingredient lists and nutritional values of 91 infant formulas were collected. The nutritional values are systematically presented for 100 g of powder, for 100 Kcal and for 100 mL of formula. The sources of fats, emulsifiers and vitamins A and E were also extracted from the ingredient lists. This dataset can be used as a tool for the formulation of infant follow-on formulas or to situate the positioning of products in relation to the market.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587705PMC
http://dx.doi.org/10.1016/j.dib.2023.109649DOI Listing

Publication Analysis

Top Keywords

infant follow-on
16
follow-on formulas
16
ingredient lists
12
nutritional values
12
infant formulas
8
formulas consumed
8
lists nutritional
8
values infant
8
infant
7
formulas
7

Similar Publications

Background: Infant formulas are the primary source of nutrition for infants and babies when breastfeeding is unavailable, as they are enriched with a variety of macro- and micronutrients to improve their nutritional value and satisfy the different needs of babies. Recently, there has been a rising concern about toxic metal levels in infant formulas, as highlighted by various studies. However, there are currently no sufficient studies focusing on toxic metal levels of infant formulas in Jordan.

View Article and Find Full Text PDF

Malawi introduced typhoid conjugate vaccine (TCV) in 2023 through an integrated campaign delivering TCV alongside other vaccines and interventions (measles rubella vaccine (MRV), bivalent oral polio vaccine (OPV), and vitamin A Supplementation). The campaign sought to reach all children 9 months to younger than 14 years, representing more than 9 million individuals, and about half the country's population. Following the campaign, TCV was incorporated into the routine immunization program for 9-month-old infants.

View Article and Find Full Text PDF

A brief history of antenatal colostrum expression, and where to from here.

Proc Nutr Soc

October 2024

Nutrition & Health Innovation Research Institute, School of Medical and Health Sciences, Nutrition & Health Innovation Research Institute, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.

The practice of antenatal colostrum expression (ACE), or the extraction of colostrum from the breasts during pregnancy, has an interesting history and continues to evolve. This narrative review aims to describe how perception and practices of ACE have changed over time, summarise the evidence on ACE in maternal and infant care, and highlight areas for future research. The literature demonstrates that ACE is safe for low-risk women when done from around 36 weeks' gestation.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to understand how long the protection from the typhoid conjugate vaccine (TCV) lasts by extending research from the TyVAC trial in Bangladesh to 5 years post-vaccination.
  • - It found that children who received the TCV between 2018-2019 had a significantly higher risk of contracting typhoid compared to those vaccinated more recently, indicating that vaccine effectiveness declines over time.
  • - The research showed an estimated vaccine effectiveness of only 50% in the 3-5 year period after vaccination, highlighting the need for further studies on booster doses to maintain immunity.
View Article and Find Full Text PDF

The endocannabinoid system (ECS) plays a major role in the maintenance of bodily homeostasis and adaptive response to external insults. It has been shown to regulate crucial physiological processes and behaviors, spanning nervous functions, anxiety, cognition, and pain sensation. Due to this broad activity, the ECS has been explored as a potential therapeutic target in the treatment of select diseases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!